India's NPPA has extended price caps on knee implants until January 15, 2027, offering relief to patients. It is also monitoring revised prices for 137 cancer drugs, effective November 9. Firms, retailers and hospitals must display new prices and fully comply with rules, while state teams will check overcharging to ensure patients receive the benefits.